---
layout: minimal-medicine
nav_exclude: true
title: Trametinib
---

# Trametinib

**Generic Name:** Trametinib

**Usage:** Trametinib is a targeted therapy used to treat certain types of cancer.  Its specific uses depend on the cancer type and stage, and often involves combination therapy with other drugs.  Common uses include:

* **Melanoma:**  Treatment of unresectable or metastatic melanoma (skin cancer) in adults, often in combination with dabrafenib (a BRAF inhibitor) or in cases where BRAF mutations are not present.
* **Non-Small Cell Lung Cancer (NSCLC):** Treatment of certain types of NSCLC (those with specific genetic mutations) in adults.  Often used in combination with other therapies.
* **Other Cancers:**  It may also be used for other cancers with specific mutations that make them sensitive to trametinib, though this is less common.  Always consult a doctor for specific treatment plans.


**Side Effects:**  Trametinib can cause a range of side effects, some common and some rare.  The severity can vary from person to person. Common side effects include:

* **Skin problems:** Rash, dryness, itching, acne-like eruption, inflammation
* **Eye problems:** Dry eyes, blurred vision
* **Gastrointestinal issues:** Diarrhea, nausea, vomiting, constipation, abdominal pain
* **Fatigue:** Feeling tired or weak
* **Muscle and joint pain (myalgia and arthralgia):**
* **Cough**
* **Increased risk of infections**
* **Elevated blood glucose**
* **Hair thinning (alopecia)**

More serious, though less common, side effects include:

* **Heart problems:**  Such as irregular heartbeat
* **Lung problems:**  Such as shortness of breath, pneumonia
* **Liver problems:**  Such as elevated liver enzymes
* **Kidney problems:**
* **Severe skin reactions**
* **Interstitial lung disease (ILD)** â€“ inflammation and scarring of the lungs.  This is a serious condition and requires immediate medical attention if symptoms develop.

This is not an exhaustive list, and you should consult your doctor or pharmacist for a complete list of potential side effects and their management.


**How it Works:** Trametinib is a MEK inhibitor.  MEK (mitogen-activated protein kinase kinase) is an enzyme involved in a signaling pathway (the MAPK/ERK pathway) that controls cell growth and division.  Many cancers have mutations that cause this pathway to be overly active, leading to uncontrolled cell growth.  Trametinib blocks the activity of MEK, thereby inhibiting this pathway and slowing or stopping cancer cell growth.


**FAQs:**

* **Is Trametinib chemotherapy?** No, Trametinib is a targeted therapy, not chemotherapy.  Targeted therapies work by targeting specific molecules involved in cancer growth, while chemotherapy drugs work more broadly to kill rapidly dividing cells.
* **How is Trametinib administered?** It is usually administered orally as a capsule.
* **How long is the treatment course?** The duration of treatment varies depending on the patient's response to the drug and the type of cancer being treated.  It's determined by the oncologist.
* **What should I do if I experience side effects?** Report any side effects to your doctor or pharmacist immediately.  Some side effects can be managed with medication or other interventions.
* **Can I take other medications with Trametinib?**  It's crucial to inform your doctor about all medications, supplements, and herbal remedies you are taking, as interactions may occur.
* **What are the long-term effects of Trametinib?** Long-term effects can vary, and ongoing monitoring is necessary. Your doctor can discuss potential long-term risks and benefits with you.


**Disclaimer:** This information is for general knowledge and does not constitute medical advice.  Always consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.  They can provide personalized guidance based on your specific situation.


**Note:** This information is AI-generated or crowd-sourced and may not be accurate. Please consult a medical professional for verified advice.